Cancer testing biotech Freenome announced on Thursday that it has raised an additional $254 million in private financing to support the development of its multiomics-based early detection tests.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,